PRKAG2 cardiac syndrome: Familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy

Current Opinion in Cardiology

Volumn 17, Issue 3, 2002, Pages 229-234

  Gollob, Michael H ^a   Green, Martin S ^b   Tang, Anthony S L ^b   Roberts, Robert ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE;

ARRHYTHMOGENESIS; BRUGADA SYNDROME; FAMILIAL DISEASE; GENE MUTATION; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MOLECULAR GENETICS; MUSCLE METABOLISM; PRIORITY JOURNAL; REVIEW; WOLFF PARKINSON WHITE SYNDROME;

ADULT; CARDIOMEGALY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MULTIENZYME COMPLEXES; PRE-EXCITATION SYNDROMES; PROTEIN-SERINE-THREONINE KINASES;

EID: 0036113920     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200205000-00004     Document Type: Review

References (48)

1. Wolff-Parkinson-White syndrome and its variants
2. Bundle branch block with short PR interval in healthy young people prone to paroxysmal tachycardia
3. Anatomy of the atrioventricular junctions with regard to ventricular preexcitation
4. Role of Mahaim fibers in cardiac arrhythmias in man
5. "Nodoventricular" accessory pathway: Evidence for a distinct accessory atrioventricular pathway with atrioventricular node-like properties
6. Accessory atrioventricular node with properties of a typical accessory pathway: Anatomic-electrophysiologic correlation
7. Re-entry: An important mechanism of cardiac arrhythmias
8. Sudden death in a young competitive athlete with Wolff-Parkinson-White syndrome
9. Ventricular preexcitation in children and young adults: Atrial myocarditis as a possible trigger of sudden death
10. Hereditary occurrence of the pre-excitation (Wolff-Parkinson White) syndrome with re-entry mechanism and concealed conduction
11. Familial occurrence of Wolff-Parkinson-White syndrome
12. A proposed autosomal dominant method of inheritance of the Wolff- Parkinson-White syndrome and supraventricular tachycardia
13. Familial Wolff-Parkinson-White syndrome
14. Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome)
15. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome
16. Familial cardiomyopathy: A new autosomal dominant form
17. Electrophysiologic characteristics of accessory atrioventricular connections in an inherited form of Wolff-Parkinson-White syndrome
18. Genetically transmitted ventricular pre-excitation in a family with hypertrophic cardiomyopathy
19. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3
20. The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex
21. AMP-activated protein kinase counteracted the inhibitory effect of glucose on the phosphoenolpyruvate carboxykinase gene expression in rat hepatocytes
22. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase
23. Congenital heart disease caused by mutations in the transcription factor NKX2-5
24. Advances in cardiovascular genetics and embryology: Role of transcription factors in congenital heart disease
25. Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase
26. Regulation of the cardiac repolarizing HERG potassium channel by protein kinase A
27. Metabolic stress and altered glucose transport: Activation of AMP- activated protein kinase as a unifying coupling mechanism
28. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle
29. Clinical approach to genetic cardiomyopathy in children
30. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding
31. Novel PRKAG2 mutation in the genetic syndrome of ventricular preexcitation and conduction defects with childhood onset and absence of cardiac hypertrophy
32. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5′-AMP-activated protein kinase, to human chromosome 7q36
33. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause hypertrophic cardiomyopathy: Evidence for the central role of energy comp disease pathogenesis
34. Mutations in PRKAG2 cause Wolff-Parkinson-White and hypertrophic cardiomyopathy
35. AMP-activated protein kinase: The energy charge hypothesis revisited
36. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy
37. Comparative study of acid maltase deficiency. Biochemical differences between infantile, childhood, and adult types
38. Hemodynamic findings in the adult form of type II glycogenosis
39. The Mount Sinai Hospital clinicalpathologic conference: A 45-year-old man with Pompe's disease and dilated cardiomyopathy
40. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients
41. Glycogen storage disease confined to the heart with deficient activity of cardiac phosphorylase kinase: A new type of glycogen storage disease
42. Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome
43. Acid maltase deficiency and related myopathies
44. Pediatric myocardial disease
45. Cardiac arrhythmias and the adult form of type II glycogenosis
46. An activating mutation in the gamma1 subunit of the AMP-activated protein kinase
47. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle
48. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle